Latest Sacroiliitis Stories
Prospective, Multi-Center Study to Evaluate Outcomes of SImmetry Sacroiliac Joint Fusion System MINNETONKA, Minn., Jan.
SAN JOSE, Calif., Sept.
MINNETONKA, Minn., May 29, 2014 /PRNewswire/ -- Zyga Technology, Inc.
Estimated Expenditure Tops $10 Billion; Afflicted Patients among Bottom 20% for Quality of Life SAN JOSE, Calif., April 14, 2014 /PRNewswire/ -- SI-BONE, Inc.
SAN JOSE, Calif., March 6, 2014 /PRNewswire/ -- SI-BONE, Inc.
SAN JOSE, Calif., Jan. 6, 2014 /PRNewswire/ -- SI-BONE, Inc.
MINNEAPOLIS, Aug. 18, 2011 /PRNewswire/ -- Zyga Technology, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the company's request to update the indications for use of its SImmetry(TM) Sacroiliac Joint Fusion System.
- A political dynamiter.